{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:48:47Z","timestamp":1765349327214,"version":"3.46.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this study is to establish a novel Renal Immune Prognostic Index (RIPI) and investigate its predictive ability for the clinical outcomes of renal cell cancer (RCC) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter retrospective study included 259 RCC patients who underwent surgical resection at the Second Affiliated Hospital of Harbin Medical University (January 2016\u2013December 2017) as the training cohort, and 350 patients from Harbin Medical University Cancer Hospital during the same period as the external validation cohort. The RIPI was developed using Cox regression with multicollinearity addressed by Lasso regression. The optimal cutoff was determined by Receiver Operating Characteristic (ROC) curve analysis. Survival differences were evaluated with Kaplan\u2013Meier curves, and potential confounding factors were adjusted using Propensity Score Matching (PSM). Model performance and clinical utility were assessed using the concordance index (C-index), calibration curves, time-dependent ROC curves, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Lasso regression identified prealbumin (PALB), lymphocyte count (LYM), and immunoglobulin M (IgM) as key hematological prognostic parameters. RIPI was constructed as: RIPI = 0.005 \u00d7 PALB (g\/L) + 0.248 \u00d7 LYM (10\n                      <jats:sup>9<\/jats:sup>\n                      \/L) + 0.372 \u00d7 IgM (g\/L). The optimal cutoff value of 4.96 stratified patients into low and high RIPI groups. In the training cohort, RIPI showed strong discriminatory ability with an AUC of 0.750, outperforming individual markers and conventional indices. Time-dependent ROC analysis demonstrated consistently higher predictive performance of RIPI across all time points. Kaplan\u2013Meier survival analysis revealed that patients in the low RIPI group had significantly shorter progression-free survival (PFS) and overall survival (OS) (all P &amp;lt; 0.001), and RIPI remained an independent prognostic factor alongside tumor size and TNM stage. After PSM, RIPI continued to demonstrate significant associations with both PFS and OS. In the validation cohort, similar results were observed, with RIPI maintaining robust prognostic value (AUC = 0.723). Nomograms incorporating RIPI achieved good calibration and C-index values, while DCA confirmed its clinical utility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This multicenter retrospective study demonstrated that RIPI, integrating PALB, LYM, and IgM, provides robust and reproducible prognostic value in RCC patients. RIPI represents a reliable and clinically applicable tool for individualized risk stratification and outcome prediction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1608847","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:44:32Z","timestamp":1765349072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishment of a novel renal immune prognostic index to predict clinical outcomes in renal cell cancer patients who received surgery"],"prefix":"10.3389","volume":"15","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2018","journal-title":"Eur Urol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat Rev Urol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2020.588215","article-title":"Robot-assisted laparoscopic living donor nephrectomy: the university of florence technique","volume":"7","author":"Serni","year":"2021","journal-title":"Front Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102558","article-title":"Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification","volume":"116","author":"Rizzo","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/nu15040880","article-title":"The geriatric nutritional risk index (GNRI) as a prognostic biomarker for immune checkpoint inhibitor response in recurrent and\/or metastatic head and neck cancer","volume":"15","author":"Haas","year":"2023","journal-title":"Nutrients"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/cancers15092531","article-title":"CD19 (+) B cell combined with prognostic nutritional index predicts the clinical outcomes of patients with gastric cancer who underwent surgery","volume":"15","author":"Sun","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40425-018-0383-1","article-title":"Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab","volume":"6","author":"Capone","year":"2018","journal-title":"J Immunother Cancer."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr.2019.11.16","article-title":"Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)","volume":"8","author":"Mandaliya","year":"2019","journal-title":"Transl Lung Cancer R"},{"key":"B9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12935-023-02902-0","article-title":"Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired","volume":"23","author":"Marei","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-animal-021419-083720","article-title":"The immunoglobulins: new insights, implications, and applications","volume":"8","author":"Sun","year":"2019","journal-title":"Annu Rev Anim Biosci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110704","article-title":"The combination of circulating IgM and geriatric nutritional risk index predicts the prognostic of hepatocellular carcinoma patients who underwent immune checkpoint inhibitors","volume":"123","author":"Liu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3937","article-title":"Association between pre-diagnostic serum albumin and cancer risk: Results from a prospective population-based study","volume":"10","author":"Yang","year":"2021","journal-title":"Cancer Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/aca.aca_114_21","article-title":"Pre-procedural serum albumin concentration is associated with length of stay, discharge destination, and 90-day mortality in patients after transcatheter aortic valve replacement","volume":"26","author":"Beydoun","year":"2023","journal-title":"Ann Card Anaesth."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.jrn.2018.09.004","article-title":"Association of pre-end-stage renal disease serum albumin with post-end-stage renal disease outcomes among patients transitioning to dialysis","volume":"29","author":"Hsiung","year":"2019","journal-title":"J Renal Nutr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0271055","DOI":"10.1371\/journal.pone.0271055","article-title":"Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study","volume":"17","author":"Ahn","year":"2022","journal-title":"PLoS One"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1421981","article-title":"Evaluation of prognostic risk factors of triple-negative breast cancer with 18F-FDG PET\/CT parameters, clinical pathological features and biochemical indicators","volume":"12","author":"Zhu","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S433245","article-title":"Development and validation of a prognostic model for transarterial chemoembolization in unresect able hepatocellular carcinoma based on preoperative serum prealbumin","volume":"10","author":"Xu","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1340286","article-title":"A novel nomogram to predict the overall survival of early-stage hepatocellular carcinoma patients following ablation therapy","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40425-016-0165-6","article-title":"Clinical significance of tumor-infiltrating lymphocytes in breast cancer","volume":"4","author":"Stanton","year":"2016","journal-title":"J Immunother Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01106-x","article-title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy","volume":"124","author":"Ng","year":"2020","journal-title":"Brit J Cancer."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23678","DOI":"10.1038\/s41598-024-75252-0","article-title":"Association between the neutrophil-to-lymphocyte ratio and cancer in adults from NHANES 2005-2018: a cross-sectional study","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1038118","article-title":"Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors","volume":"9","author":"Sun","year":"2022","journal-title":"Front Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e27378","DOI":"10.1097\/MD.0000000000027378","article-title":"Factors associated with liver cancer prognosis after hepatectomy: A retrospective cohort study","volume":"100","author":"Yuan","year":"2021","journal-title":"Medicine."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32788","article-title":"The development of a prediction model based on random survival forest for the prognosis of non- Hodgkin lymphoma: A prospective cohort study in China","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01114-0","article-title":"Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19","volume":"23","author":"Xu","year":"2023","journal-title":"Clin Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280953","article-title":"IgM monoclonal gammopathies of clinical significance: diagnosis and management","volume":"107","author":"Khwaja","year":"2022","journal-title":"Haematol-Hematol J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0156","article-title":"Innate IgM antibodies to mannose in patients with gastric cancer","volume":"21","author":"Nikulin","year":"2023","journal-title":"Cancer Biol Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells12242837","article-title":"Therapeutic monoclonal antibodies against cancer: present and future","volume":"12","author":"Delgado","year":"2023","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4095","article-title":"Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review)","volume":"34","author":"D\u00edaz-Zaragoza","year":"2015","journal-title":"Oncol Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/172460089801300204","article-title":"Preliminary evaluation of the potential prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with gastric cancer","volume":"13","author":"Tsavaris","year":"1998","journal-title":"Int J Biol Marker."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.101584","article-title":"Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort","volume":"62","author":"Peppas","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-024-01812-x","article-title":"Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival","volume":"26","author":"Karihtala","year":"2024","journal-title":"Breast Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-024-07134-4","article-title":"Universal recording of immune cell interactions in vivo","volume":"627","author":"Nakandakari-Higa","year":"2024","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: A review of evidence","volume":"139","author":"Perez","year":"2016","journal-title":"J Allergy Clin Immun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1608847\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:44:34Z","timestamp":1765349074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1608847\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":37,"alternative-id":["10.3389\/fonc.2025.1608847"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1608847","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1608847"}}